Nirashaa T Bound 35th Lorne Cancer Conference 2023

Abstracts this author is presenting:

• Why are they responding? Using immuno-genomics to understand combination PARP inhibitor plus immunotherapy response in high-grade serous ovarian cancer: SOLACE2 — Welcome Function & Poster Session I